Department of Radiology, Ajou University Hospital, Suwon, Korea.
Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
J Vasc Interv Radiol. 2022 Feb;33(2):189-196. doi: 10.1016/j.jvir.2021.10.014. Epub 2021 Oct 27.
To compare the effectiveness and safety of percutaneous transluminal angioplasty and peripherally inserted central catheter (PTA + PICC), contralateral PICC, and midline catheterization (MC) in patients with venous stenosis.
A total of 7,327 PICC procedures were performed in 5,421 patients at a single institution between 2013 and 2019. Among them, 87 patients had upper-arm venous stenoses and were managed with PTA + PICC, contralateral PICC, or MC. Data on catheter-dwell time, clinical success rate, and adverse events were recorded. The procedure was considered to have clinically succeeded when a PICC was removed from the patient just before discharge or after the completion of therapy. Catheter survival time and the chance of adverse events were compared among the groups using the Kaplan-Meier method and log-rank test.
PTA + PICC, contralateral PICC, and MC procedures were performed for 57 (65.5%, 57/87), 10 (11.5%, 10/87), and 20 (23.0%, 23/87) patients, respectively. The mean catheter-dwell time in the PTA + PICC, contralateral PICC, and MC groups was 49.7, 28.7, and 15.1 days, respectively, and the clinical success rate of each group was 86.0% (49/57), 80.0% (8/10), and 50.0% (10/20). The PTA + PICC group had a significantly longer catheter survival time than the MC group (P < .001). The chance of a catheter-related infection (P = .008) was significantly lower in the PTA + PICC group than in the MC group.
PTA + PICC or contralateral PICC should be considered prior to ipsilateral MC when venous stenosis is encountered during PICC procedures.
比较经皮腔内血管成形术联合外周中心静脉置管(PTA+PICC)、对侧 PICC 和中线置管(MC)治疗静脉狭窄患者的有效性和安全性。
在 2013 年至 2019 年期间,在一家医疗机构对 5421 名患者进行了总共 7327 例 PICC 操作。其中 87 例患者上臂静脉狭窄,采用 PTA+PICC、对侧 PICC 或 MC 治疗。记录导管留置时间、临床成功率和不良事件的数据。当 PICC 在患者出院前或治疗完成后从患者体内取出时,该手术被认为是临床成功的。使用 Kaplan-Meier 方法和对数秩检验比较组间的导管生存时间和不良事件发生机会。
PTA+PICC、对侧 PICC 和 MC 手术分别用于 57(65.5%,57/87)、10(11.5%,10/87)和 20(23.0%,23/87)名患者。PTA+PICC、对侧 PICC 和 MC 组的平均导管留置时间分别为 49.7、28.7 和 15.1 天,各组的临床成功率分别为 86.0%(49/57)、80.0%(8/10)和 50.0%(10/20)。PTA+PICC 组的导管生存时间明显长于 MC 组(P<.001)。PTA+PICC 组与 MC 组相比,导管相关性感染的机会明显较低(P=.008)。
在 PICC 操作中遇到静脉狭窄时,应考虑 PTA+PICC 或对侧 PICC,而不是同侧 MC。